Blood phosphorylated tau (p-Tau) has been shown to accurately reflect AD-associated amyloid and tau pathologies as well as distinguish AD dementia from non-AD neurodegenerative diseases [7–9]. This evidence concerns the gene MAPT and Alzheimer disease.